Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05690087

Lidocaine Infusion on Optic Nerve Sheath Diameter in Laparoscopic Hysterectomy in Trendelenburg Position

Conditions: Lidocaine, Optic Nerve Sheath Diameter, Laparoscopic Hysterectomy, Trendelenburg

Sex: Female
Ages: 35 Years – 65 Years
Phase: NA
Enrollment: 66
Sponsor: Tanta University

Location: Egypt

Summary

We hypothesize that intravenous lidocaine infusion may have beneficial effect to patients undergoing laparoscopic surgeries in Trendelenburg position by preventing ICP elevation.

Eligibility Criteria

Inclusion Criteria:Aged between 35 to 65 yearsAmerican society of anesthesiology (ASA) physical status I - IIBody mass index (BMI) between 18.5 to 28.0 kg/m2Scheduled for total laparoscopic hysterectomy taking approximately 2 h with a 30° Trendelenburg position for management of uterine fibroids or refractory dysfunctional uterine bleeding.Exclusion Criteria:Patients with eye diseases, central nervous system diseases, cardiovascular diseases, cerebrovascular diseases or diabetes.If these events occurred intraoperative:Ultrasound scans or measurements failed to clearly show the structure of Optic Nerve Sheath Diameter (ONSD).Surgical time less than 1 h.Interruption of carbon dioxide (CO2) pneumoperitoneum and Trendelenburg position.Peak airway pressure exceeding 35 cm H2OPatients with a history of allergy to lidocaine.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05690087). StuddyBuddy aggregates publicly available trial information.